Albireo Pharma, Inc.
Records under this name other than patents Albireo Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,420 | Rapid Acting and Long Acting Insulin Combination Formulations now held by Eli Lilly and Company In force · Medium confidence | In force | Medium confidence | |
| US 7,718,609 | Rapid Acting and Long Acting Insulin Combination Formulations now held by Eli Lilly and Company In force · Medium confidence | In force | Medium confidence | |
| US 9,060,927 | Insulin Formulations for Rapid Uptake now held by Eli Lilly and Company In force · High confidence | In force | High confidence | |
| US 8,637,458 | Insulin with a Stable Basal Release Profile now held by Eli Lilly and Company In force · High confidence | In force | High confidence | |
| US 9,381,247 | Magnesium Compositions for Modulating the Pharmacokinetics and Pharmacodynamics of Insulin and Insulin Analogs, and Injection Site Pain now held by Eli Lilly and Company In force · High confidence | In force | High confidence | |
| US 9,399,065 | Magnesium Compositions for Modulating the Pharmacokinetics and Injection Site Pain of Insulin now held by Eli Lilly and Company In force · High confidence | In force | High confidence | |
| US 7,279,457 | Rapid Acting Drug Delivery Compositions now held by Eli Lilly and Company Term ended Term ended Jan 21, 2026 · High confidence | Term ended | Term ended Jan 21, 2026 | High confidence |
| US 8,933,023 | Rapid Acting Injectable Insulin Compositions now held by Eli Lilly and Company Term ended Term ended Mar 11, 2025 · Medium confidence | Term ended | Term ended Mar 11, 2025 | Medium confidence |
| US 7,713,929 | Rapid Acting and Long Acting Insulin Combination Formulations now held by Eli Lilly and Company Lapsed on the fee record Ended May 11, 2022 · High confidence | Lapsed on the fee record | Ended May 11, 2022 | High confidence |
| US 9,610,329 | Stabilized Glucagon Solutions Lapsed on the fee record Ended Apr 4, 2021 · Medium confidence | Lapsed on the fee record | Ended Apr 4, 2021 | Medium confidence |